Global Biosimilar Market (2009 to 2014) MarketsandMarkets – Analyst Briefing Research Analyst :...
19
Global Biosimilar Market (2009 to 2014) MarketsandMarkets – Analyst Briefing Research Analyst : Kiran Bajaj Moderator: Manisha Shenoy
-
Upload
reginald-park -
Category
Documents
-
view
225 -
download
0
Transcript of Global Biosimilar Market (2009 to 2014) MarketsandMarkets – Analyst Briefing Research Analyst :...
Global Biosimilar Market
(2009 to 2014)
MarketsandMarkets – Analyst Briefing
Research Analyst : Kiran BajajModerator: Manisha Shenoy
What M&M can do for ABC• Key deliverables for ABC – can M&M meet your expectations?• Writing bulk market reports• Handling consulting assignments• Conducting technical research• Support database development• Flexible business model – M&M value proposition
M&M Market Reports – A Quick Insight• M&M market research reports snapshot• M&M research reports have a worldwide market share of 16.6%• Comparison of M&M reports with third-party reports• M&M market reports – types and categories• Market intelligence repository – research store of 120 full-length, strategic, and global
reports• M&M industry experts with experience from renowned publishers• Market numbers – M&M reports provide 100+ market data tables• Five-level market breakdown• Business leader insight – competitive landscape• High Level Analysis (HLA)• Matching standards- in-house publishing
About us
Agenda for the briefing
•Overview of the market
•Market trends- Opportunities, Growth factors
•Application of biosimilar- Market prospective
•Geography Analysis
•Competitive scenario
Market transition impacting Biosimilar market
The Pharmaceutical
Approach
The Biotechnology
Approach
The image cannot be displayed. Your computer may not have enough memory to open the image, or the image may have been corrupted. Restart your computer, and then open the file again. If the red x still appears, you may have to delete the image and then insert it again.The image cannot be displayed. Your computer may not have enough memory to open the image, or the image may have been corrupted. Restart your computer, and then open the file again. If the red x still appears, you may have to delete the image and then insert it again.•Chemical Based
Drugs – Non
Specific
•Biological Drugs
Based on
Recombinant
Technology Leading
To Effective
Treatment
•Enables
Production of
General Drugs
•Expanding
Scope For
Personalized and
Cluster Target
Drugs
Pharmaceutical approach
Biotechnology approach
The image cannot be displayed. Your computer may not have enough memory to open the image, or the image may have been corrupted. Restart your computer, and then open the file again. If the red x still appears, you may have to delete the image and then insert it again.The image cannot be displayed. Your computer may not have enough memory to open the image, or the image may have been corrupted. Restart your computer, and then open the file again. If the red x still appears, you may have to delete the image and then insert it again.
• Chemical based drugs non specific
•Enables production of general drugs
•Biological drugs based on peptides, recombinant technologies leading to effective treatment
•Expanding scope for personal and cluster target drugs
BiosimilarPatent expiry
Market transition
Biosimilar
Issues related with biosimilar
Comprehensive market segmentation
Generic Biosimilar Biopharmaceutical
Type of drug
Rela
tive
pric
e of
the
drug
Low
Hig
h
Pharmaceutical
Pricing of biosimilar drug
Agenda for the briefing
•Overview of the market
•Market trends- Opportunities, Growth factors
•Application of biosimilar- Market prospective
•Geography Analysis
•Competitive scenario
Biosimilar product market trend
High Price
Operational Complexities
Drug discovery
Priority
Positive
New developme
nts
Negative Factors influencing the market
Limited commerciali
zation
Cost of development
Less expensive
Pressure from insurers, and patients
Patent expiry
Risk of failure
Biosimilar market dynamics
Agenda for the briefing
•Overview of the market
•Market trends- Opportunities, Growth factors
•Application of biosimilar- Market prospective
•Geography Analysis
•Competitive scenario
Biosimilar application- Lucrative markets
Agenda for the briefing
•Overview of the market
•Market trends- Opportunities, Growth factors
•Application of biosimilar- Market prospective
•Geography Analysis
•Competitive scenario
Geography
Agenda for the briefing
•Overview of the market
•Market trends- Opportunities, Growth factors
•Application of biosimilar- Market prospective
•Geography Analysis
•Competitive scenario
Competitive Landscape
MAJOR MARKET PLAYERS
Biocon, Dr. Reddy’s lab, Intas, LG Life Sciences, Ranbaxy, Reliance LifeSciences, Sandoz, Teva, and Wockhardt
MAJOR FOCUSED SEGMENTS Biosimilar erythropoietin, insulin, G-CSF, somatotropin, interferon alpha and interferon beta
MAJOR MARKET STRATEGIESAgreements & Collaborations, New Product/Service Launch
Flexible Business Model- Our approach
M&M
100%
Cus
tom
izat
ion Q
uality
Check
Res
ourc
es &
Trai
ning
Flexible Cost
Model
“We Wait For Your Returns”
“Industry Knowledge and Prior Experience”
“We Are Open To Pilot Testing”
“You Fix Our Standards”
M&M - USP
M&M Contact Details
For queries on Biosimilar briefing - Please contact us on [email protected]
The Upcoming Reports in the Healthcare division of M&M on the following topics
• Healthcare IT market• Dental Devices market • Food Encapsulation market• Imaging information systems market• Microscopy market• Cardiology monitoring and advanced technologies market
To let us know any other topics you may be interested in please visit our website http://www.marketsandmarkets.com/ Or email us on [email protected] [email protected] for sales queries or new topics.
